TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer September 26, 2003
TCL Archive NCI Bypass Budget Justifies An Extra $900 Million In FY1992; Cancer costs Estimate At $80B A Year January 11, 1991
TCL Archive In Brief: Parkinson To Leave CTEP For Novartis; FTC To Permit Sandoz, Ciba-Geigy Merger January 10, 1997
